Prostate News Archive
07-Sep-2006
Free prostate cancer screenings well attended (The Kentucky Standard)
Although his father and grandfather both had been stricken with prostate cancer, Dr. Steve Henry, former Kentucky Lt. Governor, never gave much thought to his own chances of getting the disease. He was younger than the then recommended age 50 for annual screenings and had no symptoms. An End to Prostate Problems? Breakthrough Detoxification Research Now Being Conducted Through Tustin Longevity Center (Business Wire via Yahoo! Finance)
TUSTIN, Calif.----Sept. 6, 2006--prostate conditions such as prostatitis, enlarged prostate and prostate cancer are affecting men world-wide. In fact, more than 50% of all men 50 and over suffer from an enlarged prostate (Benign prostate Hyperplasia ). Low-risk prostate cancer: To treat or not? (Traverse City Record-Eagle)
It took eight agonizing months for Charles Linzey to decide how to treat his early-stage prostate cancer. His wife, in contrast, had her early-stage breast cancer surgically removed just a month after diagnosis. The key to surviving prostate cancer (Beaumont Enterprise)
Mark M. Hancock/The Enterprise Donald H. Taft, right, and his wife, Stella, clean the kitchen of their home in Beaumont. Donald Taft is a prostate cancer survivor. He also is a parachutist and runner. He encourages men to have regular prostate screenings to catch the disease early. St. Bernards will host free prostate cancer screenings (Trumann Democrat)
St. Bernards Medical Center will sponsor free prostate screenings Sept. 6 and 13 at the St. Bernards Auditorium, 505 East Washington Ave. Screenings, designed for men between the ages of 50 and 70, are scheduled to begin at 7 a.m. and run until noon. Project goes after high risk of prostate cancer and stroke in black men (Pittsburgh Post-Gazette)
Undeterred by evening rush-hour traffic in Oakland, 11 middle-aged black men gathered around a conference table last week to learn more about ways to prevent prostate cancer and stroke. US and Australian Biotechs Collaborate to Develop New Semen-Based Non-Invasive Prostate Cancer Test (Business Wire via Yahoo! Finance)
BOSTON----Sept. 6, 2006--Just days prior to Prostate Cancer Awareness Month a leading biotech team developing a semen-based prostate cancer test -- designed to improve on the accuracy of the prostate-specific antigen test -- has identified a prostate cancer biomarker associated with Human Carcinoma-Antigen . GTx to Continue Prostate Drug Trials (KiplingerForecasts.com)
(AP) MEMPHIS, Tenn. Biopharmaceutical company GTx Inc. said Tuesday it will continue two late-stage studies of its prostate cancer drug candidate after an independent drug safety monitoring board recommended GTx continue the research.
Back to Prostate News Archive
